PROGRAM

Wednesday April 2, 9.00-12.00 - Teaching course
Johan Zelano and Francesco Brigo

Conference room: Europa, Wallenberg Center

09.00-09.15 Welcome
Francesco Brigo, Johan Zelano 

09.15-10.00 Diagnosing epilepsy in other brain diseases 
Johan Zelano

10.00-10.30 Coffee break 

10.30-11.15 Epilepsy in patients with dementia 
Francesco Brigo

11.15-12.00 Management of seizures at and after stroke
Francesco Brigo and Johan Zelano

12.00 Lunch
for delegates at the Teaching course

Wednesday April 2, 13.00-17.00 - STESS conference

Conference room: Wallenbergsalen

Session 1: Preclinical / epileptogenesis / disease modification

13.00-13.10 Opening remarks
Francesco Brigo and Johan Zelano

13.10-13.50  Preclinical multicenter-study of TBI in rodents: results and lessons learned from the EpiBioS4Rx
Asla Pitkanen, Finland

13.50-14.30 Interleukin-1 antagonism: an antiepileptogenic treatment?
Ronny Wickström, Sweden

14.30-15.00 Coffee break

15.00-15.40 Epilepsy in brain tumors: commonalities in tumorigenesis and epileptogenesis
Eleonora Aronica, the Netherlands

15.40-16.20  Antiepileptogenesis in first seizure-patients: too late or just right?
Tony Marson, UK

16.20-17.05 Platform session
3 x 15 min presentations

Satellite symposium, sponsored by Jazz pharma:

17:15   The Burden of  Lennox Gastaut Syndrom (LGS) and Why a quality assured diagnose?
Ronny Wickström, Sweden, Adam Strzelczyk, Germany and Jukka Peltona, Finland

Welcome reception
In direct connection to the symposium, you are welcome to participate in the Welcome reception

Thursday April 3 - STESS Conference

Session 2: Biomarkers

08.20-09.00 Acute symptomatic seizures and their relation to poststroke epilepsy
Marian Galovic, Switzerland

09.00-09.40 Immune responses after seizures
Christine Ekdal, Sweden

09.40-10.20 The role of EEG in acute and structural epilepsies
Sandor Benickzy, Denmark

10.20-10.50 Coffee break

10.50-11.30  Blood biomarkers in status epilepticus
Stefano Meletti, Italy

11.30-12.00 Blood biomarkers in chronic epilepsy
Johan Zelano, Sweden 

12.00-13.00  Lunch

Session 3: Diagnosis, treatment and prognosis

13.00-13.40 Epilepsy in Alzheimer’s disease
Francesco Brigo, Italy

13.40-14.20 Status epilepticus of acute and remote symptomatic etiology
Eugen Trinka, Austria

14.20-14.50 Coffee break

14.50-15.30 Autoimmune seizures
Stephan Ruegg, Switzerland

15.30-16.10 Antiepileptic drug treatment  in patients with brain tumors
Simona Lattanzi, Italy

16.10-17.00 Platform session
3 x 15 min presentations 

Friday April 4 - STESS Conference

Session 4: Prognosis continued, Hot topics 

08.20-09.00 Polygenic risk of poststroke epilepsy
Nishant Mishra, US

09.00-09.40 Adverse cardiovascular events and ASM treatment
Josephine Mayer, UK

09.40-10.20 SUDEP in structural epilepsies
Alberto Vogrig, Italy

10.20-10.50 Coffee break

10.50-11.30  Long-term prognosis of structural epilepsy from an epidemiological perspective
Jakob Christenssen

11.30-12.10 Detecting epilepsy after eclampsia
Lina Bergman, Sweden

12.10  Lunch

Last update: 2025-01-16